“…Nimesulide caused significant hepatic damage through unpredictable adverse reactions in the liver, including increases in serum aminotransferase activities, hepatocellular necrosis, and/or intrahepatic cholestasis (Dastis et al, 2007, Merlani et al, 2001, Romero-Gomez et al, 1999, Traversa et al, 2003. Liver injury is generally assessed with histological analyses and biochemical parameters, including AST, ALT, and ALP activities and bilirubin levels in the serum.…”